Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER
Catheterization and Cardiovascular Interventions · 2026-08-03
DOI: 10.1002/ccd.70797 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, published online on 2026-08-03. Written by Fabian Voß and 14 co-authors. Institution: Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. Major MEDLINE topics: Heart Valve Prosthesis Implantation, Cardiac Catheterization, Tricuspid Valve Insufficiency, Tricuspid Valve. 17 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce. Data regarding the feasibility, safety, and treatment strategies using transcatheter valve replacement (TTVR) after T‐TEER are sparse.
Aims
Here, we aimed to summarize our early experience in TTVR after failed T‐TEER, analyze its feasibility and summarize the results in a distinct algorithm.
Methods
Patients undergoing TTVR ( n = 21) at the University Hospital of Duesseldorf were prospectively analyzed and stratified according prior T‐TEER procedures with implanted devices. Groups were compared in terms of procedural success, periprocedural complications, and patient outcomes. Individual treatment decisions for patients after T‐TEER were analyzed.
Results
Five patients had residual/recurrent severe to torrential TR and underwent TTVR after T‐TEER, whereas 16 patients were primarily referred for TTVR. Preprocedural wire‐based intentional clip excision (WICE) was performed in 60% of these patients. Patients did not differ regarding procedural success (100% in both groups, p = 0.99) and periprocedural complications (0 [TTVR after TEER] vs. 5.6% [primary TTVR], p = 0.99 for the combined endpoint of in‐hospital death, stroke, myocardial infarction, re‐intervention or surgery, and major bleeding). A pacemaker was required in one patient of each group, p = 0.4). Procedural times were higher among patients with prior T‐TEER. Treatment decisions for patients after T‐TEER were integrated into a treatment algorithm.
Conclusion
The valve after clip concept is feasible and the proposed algorithm may support procedural planning.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
- Department of Cardiac Surgery, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
- Department of Anesthesiology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
- CARID (Cardiovascular Research Institute Düsseldorf), Düsseldorf, Germany.
ORCID profiles: Fabian Voß
Cite
APA
Voß, F., Mourikis, P., Nienhaus, F., Haschemi, J., Hoss, A., Zeus, T., Kowalski, H., Spieker, M., Jung, C., Horn, P., Aubin, H., Lichtenberg, A., Truse, R., Kelm, M., & Polzin, A. (2026). Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70797
Vancouver
Voß F, Mourikis P, Nienhaus F, Haschemi J, Hoss A, Zeus T, et al. Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70797
BibTeX
@article{Vo2026,
author = {Voß, Fabian and Mourikis, Philipp and Nienhaus, Fabian and Haschemi, Jafer and Hoss, Alexander and Zeus, Tobias and Kowalski, Hanna and Spieker, Maximilian and Jung, Christian and Horn, Patrick and Aubin, Hug and Lichtenberg, Artur and Truse, Richard and Kelm, Malte and Polzin, Amin},
title = {Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70797}
}
EUVIMED